A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study. (21st September 2016) - Kirschbaum, Mark H.; Frankel, Paul; Synold, Timothy W.; Zain, Jasmine; Claxton, David; Tuscano, Joseph; Newman, Edward M.; Gandara, David R.; Lara, Primo N.